Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Stemtech (STEK) Liabilities and Shareholders Equity (2020 - 2025)

Stemtech (STEK) has disclosed Liabilities and Shareholders Equity for 6 consecutive years, with $3.8 million as the latest value for Q3 2025.

  • Quarterly Liabilities and Shareholders Equity changed N/A to $3.8 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $15.2 million through Sep 2025, up 38.04% year-over-year, with the annual reading at $3.8 million for FY2024, 2.69% up from the prior year.
  • Liabilities and Shareholders Equity hit $3.8 million in Q3 2025 for Stemtech, down from $3.9 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $6.3 million in Q3 2021 to a low of $3.6 million in Q1 2024.
  • Historically, Liabilities and Shareholders Equity has averaged $4.4 million across 5 years, with a median of $4.2 million in 2022.
  • Biggest five-year swings in Liabilities and Shareholders Equity: grew 14.19% in 2021 and later tumbled 30.68% in 2022.
  • Year by year, Liabilities and Shareholders Equity stood at $5.7 million in 2021, then dropped by 25.4% to $4.3 million in 2022, then dropped by 13.68% to $3.7 million in 2023, then grew by 2.69% to $3.8 million in 2024, then fell by 0.7% to $3.8 million in 2025.
  • Business Quant data shows Liabilities and Shareholders Equity for STEK at $3.8 million in Q3 2025, $3.9 million in Q2 2025, and $3.8 million in Q1 2025.